TNDM - TANDEM DIABETES CARE INC


22.63
-0.780   -3.447%

Share volume: 1,538,453
Last Updated: 03-05-2026
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies: -0.03%

PREVIOUS CLOSE
CHG
CHG%

$23.41
-0.78
-0.03%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
41%
Profitability 25%
Dept financing 50%
Liquidity 40%
Performance 55%
Company vs Stock growth
vs
Performance
5 Days
-10.31%
1 Month
18.05%
3 Months
9.11%
6 Months
81.04%
1 Year
20.89%
2 Year
-16.40%
Key data
Stock price
$22.63
P/E Ratio 
0.00
DAY RANGE
$22.31 - $23.22
EPS 
-$3.04
52 WEEK RANGE
$9.98 - $29.65
52 WEEK CHANGE
$26.00
MARKET CAP 
1.490 B
YIELD 
N/A
SHARES OUTSTANDING 
68.326 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
07-31-2025
BETA 
1.52
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$3,219,364
AVERAGE 30 VOLUME 
$2,744,971
Company detail
CEO: John F. Sheridan
Region: US
Website: tandemdiabetes.com
Employees: 2,600
IPO year: 2007
Issue type: Common Stock
Market: XNAS
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing

Tandem Diabetes Care, Inc. designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system. It also offers t:connect, a web-based data management application, continuous glucose monitoring, and supported blood glucose meters.

Recent news